Pete if you think 10 cents is all we gonna get out of the IND filing. If so then we going to have 6 months of trial to which I don't see it climbing any until we may get close to the end of trial. Then maybe some buying close to end. But back to 10 cents if that's the case I will put a stop loss right under it and let it trickle back down like it did on first clinical trial and then buy back in doubling up or more on shares. I will be very disappointed if its just a dime.
My guess would be 25 to 40 cent range. But that's is a guess to which I will admit I know nothing about.
Market Data 
Markets 
AI
